Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and preliminary efficacy of
microplasmin when administered intravenously to patients who have suffered an acute stroke
within 12 hours before randomization.